GKL-Biotec

About GKL-Biotec

GKL BIOTEC AG - a subsidiary of the company group Klett-Loch Based on continuous and intensive research on active pharmaceutical ingredients (API’s) in the field of Thymic Peptides, the company GKL-BIOTEC-AG was founded in January 2008. We focus on the development of active ingredients for the pharmaceutical and cosmetics industry. In close cooperation with renowned universities we promote the technological transfer of biochemical innovations. The existing results have underlined the success of our approach. Thymic peptides are known as key molecules for the effectivity of the human immune system. Regulatory effects of thymic peptides on T-cell functions were already discovered in the 1980s by Goldstein, Stevenson, Fauci etc., currently continued and reconfirmed by Professor Richard Boyd. Professor C. Birr (Heidelberg) developed within the scope of a seven year research project a bovine-free mimicry of the natural total thymus extract = bovine-free statistic thymic tetra peptide library The bovine-free peptide library GKL-02/03 is highly effective, save, patented, worldwide unique and bears decisive advantages vs. the natural thymic total extract. Not to be confused with a polymer.

View contact profiles from GKL-Biotec